TABLE OF CONTENTS
|  | | | Volume 108, Issue 4 (745-996)
Published online 5 March 2013
|  | In this issue
 Editorial
Minireviews
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics
Letters to the Editor
Book Review
Also new today
 Advance online publication
| | | | | | Advertisement | | | | | | | | World CTC Berlin - Unleashing the potential of circulating tumour cells & demonstrating practical applications in the clinic
• Advanced technology applications
• Novel biomarker research
• Defined clinical utility
• 44 expert speakers, 2 streams and 3 interactive workshops
Download the brochure here
23-25 April 2013
www.worldctc-berlin.com | 
| | | | | Editorial | Top | | Pathology vs medical oncology: the crucial exchange of accurate information S Dawood Br J Cancer 2013 108: 745-747; 10.1038/bjc.2013.23 Full Text | | Minireviews | Top | | Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair B Groselj, N L Sharma, F C Hamdy, M Kerr and A E Kiltie Br J Cancer 2013 108: 748-754; advance online publication, January 29, 2013; 10.1038/bjc.2013.21 Abstract | Full Text | | | | Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis G S Wong and A K Rustgi Br J Cancer 2013 108: 755-761; advance online publication, January 15, 2013; 10.1038/bjc.2012.592 Abstract | Full Text | | Clinical Studies | Top | | A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies R D Harvey, T K Owonikoko, C M Lewis, A Akintayo, Z Chen, M Tighiouart, S S Ramalingam, M P Fanucchi, P Nadella, A Rogatko, D M Shin, B El-Rayes, F R Khuri and J S Kauh Br J Cancer 2013 108: 762-765; advance online publication, January 15, 2013; 10.1038/bjc.2012.604 Abstract | Full Text | | | | Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer V Heinemann, M P Ebert, R P Laubender, P Bevan, C Mala and S Boeck Br J Cancer 2013 108: 766-770; advance online publication, February 14, 2013; 10.1038/bjc.2013.62 Abstract | Full Text | | | | Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial N C Tebbutt, M M Parry, D Zannino, A H Strickland, G A Van Hazel, N Pavlakis, V Ganju, D Mellor, A Dobrovic and V J Gebski on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG) Br J Cancer 2013 108: 771-774; advance online publication, February 14, 2013; 10.1038/bjc.2013.41 Abstract | Full Text | | | | Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997–2004 O Dejardin, B Rachet, E Morris, V Bouvier, V Jooste, R Haynes, E G Coombes, D Forman, A P Jones, A M Bouvier and G Launoy Br J Cancer 2013 108: 775-783; advance online publication, February 7, 2013; 10.1038/bjc.2013.33 Abstract | Full Text | | | | Innovative estimation of survival using log-normal survival modelling on ACCENT database J W Chapman, C J O'Callaghan, N Hu, K Ding, G A Yothers, P J Catalano, Q Shi, R G Gray, M J O'Connell and D J Sargent for the ACCENT collaborative group Br J Cancer 2013 108: 784-790; advance online publication, February 5, 2013; 10.1038/bjc.2013.34 Abstract | Full Text | | | | Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer C-Y Lu, H-L Tsai, Y-H Uen, H-M Hu, C-W Chen, T-L Cheng, S-R Lin and J-Y Wang Br J Cancer 2013 108: 791-797; advance online publication, February 19, 2013; 10.1038/bjc.2012.595 Abstract | Full Text | | | | The association between physical activity and renal cancer: systematic review and meta-analysis G Behrens and M F Leitzmann Br J Cancer 2013 108: 798-811; advance online publication, February 14, 2013; 10.1038/bjc.2013.37 Abstract | Full Text | | | | Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study L Holmberg, Y N S Wong, L Tabár, A Ringberg, P Karlsson, L-G Arnesson, K Sandelin, H Anderson, H Garmo and S Emdin on behalf of the Swedish Breast Cancer Group Br J Cancer 2013 108: 812-819; advance online publication, January 31, 2013; 10.1038/bjc.2013.26 Abstract | Full Text | | | | Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy J J Jobsen, J van der Palen, M Baum, M Brinkhuis and H Struikmans Br J Cancer 2013 108: 820-825; advance online publication, February 5, 2013; 10.1038/bjc.2013.36 Abstract | Full Text | | | | Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma A Naing, P LoRusso, S Fu, D Hong, H X Chen, L A Doyle, A T Phan, M A Habra and R Kurzrock Br J Cancer 2013 108: 826-830; advance online publication, February 14, 2013; 10.1038/bjc.2013.46 Abstract | Full Text | | | | Health behaviour advice to cancer patients: the perspective of social network members K Williams, R J Beeken and J Wardle Br J Cancer 2013 108: 831-835; advance online publication, February 7, 2013; 10.1038/bjc.2013.38 Abstract | Full Text | | Translational Therapeutics | Top | | Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma Y Fujiwara-Okada, Y Matsumoto, J Fukushi, N Setsu, S Matsuura, S Kamura, T Fujiwara, K Iida, M Hatano, A Nabeshima, H Yamada, M Ono, Y Oda and Y Iwamoto Br J Cancer 2013 108: 836-847; 10.1038/bjc.2012.579 Abstract | Full Text | | | | Oxidative stress specifically downregulates survivin to promote breast tumour formation S Pervin, L Tran, R Urman, M Braga, M Parveen, S A Li, G Chaudhuri and R Singh Br J Cancer 2013 108: 848-858; advance online publication, February 12, 2013; 10.1038/bjc.2013.40 Abstract | Full Text | | | | Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein M Harris, X G Wang, Z Jiang, R Phaeton, W Koba, G L Goldberg, A Casadevall and E Dadachova Br J Cancer 2013 108: 859-865; advance online publication, February 5, 2013; 10.1038/bjc.2013.43 Abstract | Full Text | | | | A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial E Provenzano, A-L Vallier, R Champ, K Walland, S Bowden, A Grier, N Fenwick, J Abraham, M Iddawela, C Caldas, L Hiller, J Dunn and H M Earl Br J Cancer 2013 108: 866-872; advance online publication, January 8, 2013; 10.1038/bjc.2012.547 Abstract | Full Text | | Molecular Diagnostics | Top | | Multiparameter DNA content analysis identifies distinct groups in primary breast cancer J H S Dayal, M J Sales, W E Corver, C A Purdie, L B Jordan, P R Quinlan, L Baker, N T ter Haar, N R Pratt and A M Thompson Br J Cancer 2013 108: 873-880; advance online publication, February 14, 2013; 10.1038/bjc.2013.42 Abstract | Full Text | | | | Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer B T F van der Gun, C Huisman, S Stolzenburg, H G Kazemier, M H J Ruiters, P Blancafort and M G Rots Br J Cancer 2013 108: 881-886; advance online publication, February 12, 2013; 10.1038/bjc.2013.45 Abstract | Full Text | | | | Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib B Beuselinck, A Karadimou, D Lambrechts, B Claes, P Wolter, G Couchy, J Berkers, R Paridaens, P Schöffski, A Méjean, V Verkarre, E Lerut, A de la Taille, J-M Tourani, P Bigot, C Linassier, S Négrier, J Berger, J-J Patard, J Zucman-Rossi and S Oudard Br J Cancer 2013 108: 887-900; 10.1038/bjc.2012.548 Abstract | Full Text | | | | Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients M Pichler, G C Hutterer, C Stoeckigt, T F Chromecki, T Stojakovic, S Golbeck, K Eberhard, A Gerger, S Mannweiler, K Pummer and R Zigeuner Br J Cancer 2013 108: 901-907; advance online publication, February 5, 2013; 10.1038/bjc.2013.28 Abstract | Full Text | | | | Comparing the performance of six human papillomavirus tests in a screening population J Cuzick, L Cadman, D Mesher, J Austin, L Ashdown-Barr, L Ho, G Terry, S Liddle, C Wright, D Lyons and A Szarewski Br J Cancer 2013 108: 908-913; advance online publication, January 31, 2013; 10.1038/bjc.2013.22 Abstract | Full Text | | | | Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer Y Ino, R Yamazaki-Itoh, K Shimada, M Iwasaki, T Kosuge, Y Kanai and N Hiraoka Br J Cancer 2013 108: 914-923; advance online publication, February 5, 2013; 10.1038/bjc.2013.32 Abstract | Full Text | | | | BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma J S Wilmott, A M Menzies, L E Haydu, D Capper, M Preusser, Y E Zhang, J F Thompson, R F Kefford, A von Deimling, R A Scolyer and G V Long Br J Cancer 2013 108: 924-931; advance online publication, February 12, 2013; 10.1038/bjc.2013.29 Abstract | Full Text | | | | Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model P Rotkrua, S Shimada, K Mogushi, Y Akiyama, H Tanaka and Y Yuasa Br J Cancer 2013 108: 932-940; advance online publication, February 5, 2013; 10.1038/bjc.2013.30 Abstract | Full Text | | | | A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions Z-q Xu, Y Y Broza, R Ionsecu, U Tisch, L Ding, H Liu, Q Song, Y-y Pan, F-x Xiong, K-s Gu, G-p Sun, Z-d Chen, M Leja and H Haick Br J Cancer 2013 108: 941-950; 10.1038/bjc.2013.44 Abstract | Full Text | | | | Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms G Nishikawa, S Sekine, R Ogawa, A Matsubara, T Mori, H Taniguchi, R Kushima, N Hiraoka, K Tsuta, H Tsuda and Y Kanai Br J Cancer 2013 108: 951-958; advance online publication, February 12, 2013; 10.1038/bjc.2013.47 Abstract | Full Text | | Genetics and Genomics | Top | | Male breast cancer, age and sex chromosome aneuploidy P A Jacobs, V Maloney, R Cooke, J A Crolla, A Ashworth and A J Swerdlow Br J Cancer 2013 108: 959-963; advance online publication, January 8, 2013; 10.1038/bjc.2012.577 Abstract | Full Text | | | | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression N Presneau, M Eskandarpour, T Shemais, S Henderson, D Halai, R Tirabosco and A M Flanagan Br J Cancer 2013 108: 964-972; advance online publication, November 22, 2012; 10.1038/bjc.2012.518 Abstract | Full Text | | | | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients N Wagener, J Bulkescher, S Macher-Goeppinger, I Karapanagiotou-Schenkel, G Hatiboglu, M Abdel-Rahim, H Abol- Enein, M A Ghoneim, P J Bastian, S C Müller, A Haferkamp, M Hohenfellner, F Hoppe-Seyler and K Hoppe-Seyler Br J Cancer 2013 108: 973-982; advance online publication, January 8, 2013; 10.1038/bjc.2012.573 Abstract | Full Text | | | | Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress M Hewish, S A Martin, R Elliott, D Cunningham, C J Lord and A Ashworth Br J Cancer 2013 108: 983-992; advance online publication, January 29, 2013; 10.1038/bjc.2013.3 Abstract | Full Text | | Letters to the Editor | Top | | Comment on ‘Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells’ B Cvek Br J Cancer 2013 108: 993; advance online publication, January 22, 2013; 10.1038/bjc.2013.18 Full Text | | | | Reply: Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells P Liu, S Brown, P Channathodiyil, V Kannappan, A L Armesilla, J L Darling and W Wang Br J Cancer 2013 108: 994; advance online publication, January 22, 2013; 10.1038/bjc.2013.19 Full Text | | Book Review | Top | | Primary liver cancer T Meyer Br J Cancer 2013 108: 995-996; 10.1038/bjc.2013.52 Full Text | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment
Keep a civil tongue.